Application of biological markers of kidney injury for prognosis of long-term adverse outcomes in patients with ST-segment elevation myocardial infarction
Objective: To study the prognostic significance of serum NGAL (sNGAL) and cystatin C in the acute phase of ST-segment elevation myocardial infarction (STEMI) in the late disease period. Material and Methods: 357 patients with STEMI, admitted to hospital within 24 h of symptom onset, were include...
Main Authors: | O. L. Barbarash, I. S. Bykova, V. V. Kashtalap, M. V. Zykov, O. N. Khryachkova, V. V. Kalaeva, K. S. Shafranskaya, V. N. Karetnikova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics
2014-09-01
|
Series: | Атеросклероз |
Subjects: | |
Online Access: | https://ateroskleroz.elpub.ru/jour/article/view/716/658 |
Similar Items
-
ROLE OF THE SERUM NGAL FOR ASSESSMENT OF HOSPITAL PROGNOSIS IN MEN WITH ST ELEVATION MYOCARDIAL INFARCTION
by: V. N. Karetnikova, et al.
Published: (2015-06-01) -
CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION
by: M. V. Zykov, et al.
Published: (2015-11-01) -
The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction
by: V N Karetnikova, et al.
Published: (2016-06-01) -
Galectin-3 – prospective biomarker of risk stratification in patients with ST-segment elevation myocardial infarction
by: N. V. Fedorova, et al.
Published: (2015-12-01) -
Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction.
by: Victoria Karetnikova, et al.
Published: (2017-01-01)